---
schema_version: "secwatch.filing_event.v1"
accession: "0001641489-23-000082"
form_type: "8-K"
ticker: "VTVT"
cik: "0001641489"
company_name: "vTv Therapeutics Inc."
filed_at: "2023-12-12T23:59:59+00:00"
generated_at: "2026-06-07T14:14:48.500483+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# vTv Therapeutics regains Nasdaq minimum bid compliance after reverse stock split

## Summary
- Nasdaq notified vTv on Dec 11, 2023 that it regained $1.00 minimum bid price compliance.
- Company had received deficiency letter on Dec 22, 2022; extended deadline to Dec 18, 2023.
- Effected a reverse stock split on Nov 20, 2023 to meet the bid price requirement.
- Listing of common stock on Nasdaq Capital Market will continue.

## SEC filing metadata
- accession: 0001641489-23-000082
- form_type: 8-K
- ticker: VTVT
- cik: 0001641489
- company_name: vTv Therapeutics Inc.
- filed_at: 2023-12-12T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641489/000164148923000082/0001641489-23-000082-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641489/000164148923000082/vtvt-20231211.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641489-23-000082
- JSON: https://secwatch.observer/filing/0001641489-23-000082.json
- Plain text: https://secwatch.observer/filing/0001641489-23-000082.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.